Noncardiac drugs and QTc interval prolongation: an often unrecognized risk factor for adverse cardiovascular outcomes.
Sander
Gary E
GE
Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Guillory
Gregory S
GS
Giles
Thomas D
TD
D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects*; D000932:Antiemetics / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D018692:Antimanic Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000150:complications*; D004347:Drug Interactions; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D000928:Antidepressive Agents; D000932:Antiemetics; D000959:Antihypertensive Agents; D018692:Antimanic Agents; D014150:Antipsychotic Agents